NCT07159620
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
297 public trials
56 recruiting studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results
NCT06855810
- Conditions
- Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, Hematologic Diseases, +12 more
- Locations
-
- Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
- Anhui Provincial Children's Hospital Hefei, Anhui, China
- Chongqing Medical University Affiliated Children's Hospital Chongqing, Chongqing Municipality, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
NCT07021677
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Dr.Sumeet Mirgh Navi Mumbai, Maharashtra, India
Recruiting
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
NCT07012447
- Conditions
- Digestive System Diseases, Early T Acute Lymphoblastic Leukemia, Gastric Outlet Obstruction, +19 more
- Locations
-
- Ethical Committee of the First Affliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT06686108
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplantation, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- Shanghai General Hospital Shanghai, China
NCT06462365
- Conditions
- Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, Adult T-Cell, Acute Myeloid Leukemia in Remission, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Recruiting
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
NCT06909474
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
NCT06420076
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
- Locations
-
- District One Hospital Beijing, Beijing Municipality, China
NCT06633341
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China
NCT06633354
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China